KYOTO, Japan--(BUSINESS WIRE)--The Orthopedics Division at National Hospital Organization, Kyoto Medical Center, announced that it has confirmed the efficacy of Theracrumin®, absorption enhanced curcumin*1 on knee osteoarthritis, based on the clinical trial conducted by the group of researchers.
Knee osteoarthritis is a disease that provokes pains in knee junctions and cartilage, and is mainly caused by ageing. It is said that there are twenty million patients in Japan. The prevailing treatments for this disease today include the prescription of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), physical therapy, knee joint Hyaluronic acid injection, and surgical operation.
Help employers find you! Check out all the jobs and post your resume.
